Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 May;111(5):775–785. doi: 10.1289/ehp.5948

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions.

Christian G Daughton 1
PMCID: PMC1241488  PMID: 12727607

Abstract

Since the 1980s, the occurrence of pharmaceuticals and personal care products (PPCPs) as trace environmental pollutants, originating primarily from consumer use and actions rather than manufacturer effluents, continues to become more firmly established. The growing, worldwide importance of freshwater resources underscores the need for ensuring that any aggregate or cumulative impacts on (or from) water supplies are minimized. Despite a paucity of effects data from long-term, simultaneous exposure at low doses to multiple xenobiotics (particularly non-target-organism exposure to PPCPs), a wide range of proactive actions could be implemented for reducing or minimizing the introduction of PPCPs to the environment. Most of these actions fall under what could be envisioned as a holistic stewardship program--overseen by the health care industry and consumers alike. Significantly, such a stewardship program would benefit not just the environment--additional, collateral benefits could automatically accrue, including the lessening of medication expense for the consumer and improving patient health and consumer safety. In this article (the second of two parts describing the "green pharmacy") I focus on those actions and activities tied more closely to the end user (e.g., the patient) and issues associated with drug disposal/recycling that could prove useful in minimizing the environmental disposition of PPCPs. I also outline some recommendations and suggestions for further research and pose some considerations regarding the future. In this mini-monograph I attempt to capture cohesively for the first time the wide spectrum of actions available for minimizing the release of PPCPs to the environment. A major objective is to generate an active dialog or debate across the many disciplines that must become actively involved to design and implement a successful approach to life-cycle stewardship of PPCPs.

Full Text

The Full Text of this article is available as a PDF (150.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bessho Yoshitaka, Hodgson David R. W., Suga Hiroaki. A tRNA aminoacylation system for non-natural amino acids based on a programmable ribozyme. Nat Biotechnol. 2002 Jul;20(7):723–728. doi: 10.1038/nbt0702-723. [DOI] [PubMed] [Google Scholar]
  2. Blount B. C., Silva M. J., Caudill S. P., Needham L. L., Pirkle J. L., Sampson E. J., Lucier G. W., Jackson R. J., Brock J. W. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect. 2000 Oct;108(10):979–982. doi: 10.1289/ehp.00108979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boehm Alexandria B., Sanders Brett F., Winant Clinton D. Cross-shelf transport at Huntington Beach. Implications for the fate of sewage discharged through an offshore ocean outfall. Environ Sci Technol. 2002 May 1;36(9):1899–1906. doi: 10.1021/es0111986. [DOI] [PubMed] [Google Scholar]
  4. Daughton C. G., Ternes T. A. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect. 1999 Dec;107 (Suppl 6):907–938. doi: 10.1289/ehp.99107s6907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goldman L. R., Shannon M. W., American Academy of Pediatrics: Committee on Environmental Health Technical report: mercury in the environment: implications for pediatricians. Pediatrics. 2001 Jul;108(1):197–205. doi: 10.1542/peds.108.1.197. [DOI] [PubMed] [Google Scholar]
  6. Greene L. A. Controversy swirls around toilet-to-tap project. Environ Health Perspect. 2000 Oct;108(10):A447–A447. doi: 10.1289/ehp.108-a447a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gurwitz Jerry H., Rochon Paula, Food and Drug Administration (U.S.) Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002 Aug 12;162(15):1670–1672. doi: 10.1001/archinte.162.15.1670. [DOI] [PubMed] [Google Scholar]
  8. Harder U., Reutter R., Luyben A., Gross M. M. Hebammen präferieren vaginale Geburt statt Wunschsektio1. Z Geburtshilfe Neonatol. 2002 Apr;206(2):72–74. doi: 10.1055/s-2002-30140. [DOI] [PubMed] [Google Scholar]
  9. Heberer Thomas. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett. 2002 May 10;131(1-2):5–17. doi: 10.1016/s0378-4274(02)00041-3. [DOI] [PubMed] [Google Scholar]
  10. Kaur Indu Pal, Chopra Kanwaljit, Saini Amarpreet. Probiotics: potential pharmaceutical applications. Eur J Pharm Sci. 2002 Feb;15(1):1–9. doi: 10.1016/s0928-0987(01)00209-3. [DOI] [PubMed] [Google Scholar]
  11. Kolpin Dana W., Furlong Edward T., Meyer Michael T., Thurman E. Michael, Zaugg Steven D., Barber Larry B., Buxton Herbert T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol. 2002 Mar 15;36(6):1202–1211. doi: 10.1021/es011055j. [DOI] [PubMed] [Google Scholar]
  12. Kuspis D. A., Krenzelok E. P. What happens to expired medications? A survey of community medication disposal. Vet Hum Toxicol. 1996 Feb;38(1):48–49. [PubMed] [Google Scholar]
  13. Larsen T. A., Peters I., Alder A., Eggen R., Maurer M., Muncke J. Re-engineering the toilet for sustainable waste water management. Environ Sci Technol. 2001 May 1;35(9):192A–197A. doi: 10.1021/es012328d. [DOI] [PubMed] [Google Scholar]
  14. Leuchter Andrew F., Cook Ian A., Witte Elise A., Morgan Melinda, Abrams Michelle. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry. 2002 Jan;159(1):122–129. doi: 10.1176/appi.ajp.159.1.122. [DOI] [PubMed] [Google Scholar]
  15. Otterpohl R. Options for alternative types of sewerage and treatment systems directed to improvement of the overall performance. Water Sci Technol. 2002;45(3):149–158. [PubMed] [Google Scholar]
  16. Pitkala Kaisu H., Strandberg Timo E., Tilvis Reijo S. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med. 2002 Aug 12;162(15):1707–1712. doi: 10.1001/archinte.162.15.1707. [DOI] [PubMed] [Google Scholar]
  17. Reid G., Howard J., Gan B. S. Can bacterial interference prevent infection? Trends Microbiol. 2001 Sep;9(9):424–428. doi: 10.1016/s0966-842x(01)02132-1. [DOI] [PubMed] [Google Scholar]
  18. Renner Rebecca. Do cattle growth hormones pose an environmental risk? Environ Sci Technol. 2002 May 1;36(9):194A–197A. doi: 10.1021/es022301+. [DOI] [PubMed] [Google Scholar]
  19. Velagaleti Ranga, Burns Philip K., Gill Michael, Prothro James. Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal. Environ Health Perspect. 2002 Mar;110(3):213–220. doi: 10.1289/ehp.02110213. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES